The findings demonstrate a sustained overall survival (OS) benefit in a broad population of patients with stage II and III ...

Bristol Myers Squibb (BMS) and SystImmune have reported positive Phase 3 results for izalontamab brengitecan (iza-bren), an ...

Amaha, an integrated mental healthcare organisation, is set to close a Rs 100 crore fundraise to expand its hospital and ...

LGM Pharma has acquired Sannova Analytical, a New Jersey-based contract research laboratory, in a move that expands its US ...

The findings position remibrutinib as a potential new treatment option for patients seeking sustained disease control without chronic B-cell depletion. Results from the REMODEL-1 and REMODEL-2 trials ...

The research will focus on disease-progression modelling, predictive outcome modelling and advanced clinical trial ...

US-based global biopharmaceutical company Amneal Pharmaceuticals has inaugurated a new administrative office in Ahmedabad ...

Abbott plans to spin off its Nutrition business into an independent, publicly traded company, creating a global player with ...

The United States Food and Drug Administration (USFDA) has conducted an unannounced inspection on Current Good Manufacturing ...

Global pharma major Lupin Limited (Lupin) announced the appointment of Brian Savage as President, Chief Legal Officer. Brian ...

Gufic Biosciences Limited announced that the United States Food and Drug Administration (USFDA) conducted a Pre-Approval ...

Kilitch Drugs (India) Limited is exiting its Ethiopian subsidiary in a $14 million deal, sharpening its focus on domestic ...